In the wild-type model fed the high-fat diet, the authors observed that resveratrol treatment reduced glucose intolerance (as determined by a glucose tolerance test), tripled the concentration of active GLP-1 in the portal vein, increased intestinal glucagon and active GLP-1 and increased insulin concentration during the glucose tolerance test. The gene discussed is INS; the disease is glucose measurement.